Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study

Marta Di Forti, Arianna Marconi, Elena Carra, +20

The Lancet Psychiatry

High-potency cannabis and the risk of psychosis

Marta Di Forti, Craig Morgan, Paola Dazzan, +12

The British Journal of Psychiatry

Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications

Katherine E. Burdick, Manuela Russo, Sophia Frangou, +4

Psychological Medicine

Corrosion protection of magnesium by electroactive polypyrrole/paint coatings

V.-T. Truong, Pingsheng Lai, B. Moore, +2

Synthetic Metals

Materials ScienceCorrosion ProtectionEngineeringCorrosionProtective Coatings +2

Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis

Monica Aas, Paola Dazzan, Valeria Mondelli, +16

Psychological Medicine

How to measure the impact of the COVID-19 pandemic on quality of life: COV19-QoL – the development, reliability and validity of a new scale

Selman Repišti, Nikolina Jovanović, Martina Rojnić Kuzman, +13

Global Psychiatry

Quality Of LifeGeriatric PsychiatryPsychological Co-morbiditiesLife AssessmentPsychiatric Evaluation +19

Jumping to Conclusions, Neuropsychological Functioning, and Delusional Beliefs in First Episode Psychosis

M. Aurora Falcone, Robin Murray, B. Wiffen, +12

Schizophrenia Bulletin

Association Between Symptom Dimensions and Categorical Diagnoses of Psychosis: A Cross-sectional and Longitudinal Investigation

Manuela Russo, Stephen Z. Levine, Arsime Demjaha, +9

Schizophrenia Bulletin

Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings

Manuela Russo, Tamsyn E. Van Rheenen, Megan Shanahan, +6

Psychological Medicine

Social Disadvantage: Cause or Consequence of Impending Psychosis?

Simona A. Stilo, Marta Di Forti, Valeria Mondelli, +15

Schizophrenia Bulletin